The Role of PTEN Gene Deletion In Prostate Cancer In Relation To Proliferative Capability of Malignant Cells

Nabeel Tawfeeq Kammuna,Kaswr Mosa Al-Taraihi,Asaad Abdullhamza Al-janabi
Authors Emails are requested on demand or by logging in
Keywords : PTEN- phosphatase and tension,Akt- Antigen Kinase Thymoma,CISH-chromogenic in situ hybridization, FISH- Flurescent in situ hybridization.
Medical Journal of Babylon  13:3 , 2016 doi:1812-156X-13-3
Published :31 December 2016


PTEN gene is a tumor suppressor gene located in 10q23,3 that encode dual- specificity protein and lipid phospatase with tensinhomologe. The PTEN protein signals adjust cell splitting up and express cells to enter normal cell death way. defeat of PTEN leads to over –foundation of AKt, which in circle , is related with unrestrained cell production. In this cross section study, we examined 50 paraffin-embedded blocks belongs to 50 patients with proved prostate cancer, All slides subjected to IHC KI67 Ab ( which is a parameter of proliferative activity of malignant cells), and to 1 molecular study of PTEN gene in all tissues by using CISH technique. The association between PTEN gene status examined by CISH technique with KI67 score performed by IHC technique , is highly significant, in that we get 71.43% (25/35) of no deletion cases had KI67 score ?10% of cells, while in cases with PTEN gene deletion , we had 73.33% (11/15) of cases carry KI67 score >10% of cells


Prostatic cancer is still one of the major health problems all over the world ,and is one of the leader causes of cancer deathin men. It forms a significant percentage of hidden malignancies existing with secondary metastasis. prostate cancers exhibit a unevenvariety of clinical and behavioral forms,ranging from sluggish-mounting tumors of slight clinical consequence to extremely aggressive metastatic and deadly disease [1]. The PTEN gene, is a tumor suppressor gene located on chromosome 10q23,3 that encodes a dual-specificity protein and lipid phosphatase and tensin homolog , it targets the PIP3, converting it back to PIP2 has an important role in determine the aggressive behavior of prostate cancer[2]. PTEN protein signals regulates cell dissection and can also straight cells to go into a usual cell death lane. As a controller of PI3K signaling [3], defeat of PTEN leads to over –establishment of AKt, which in turn, is coupled with unrestrained cell production, reduce apoptosis, and angiogenesis [4].Inactivation of PTEN is frequent in prostate cancer, especially the metastatic types [5]. The Ki-67 antigen was initiallyrecognized by a German researchers in the 1980, it is a non-histone protein was [6]. researches have documented the contribution of Ki-67 in the polymerase ribosomal RNA synthesis. the protein has an vitalrole in cell separation, its exactrole is still ambiguous [7]. Mostly, Ki-67 is calculated on paraffin blocks by animmunohistochemical technique. overall, the Ki-67 gain is distinct as the proportion of whole number of malignant cells that have nuclear staining [7], So by using the KI-67 expression inparaffin embedded sections, enable us to predict the prostatic carcinoma prognosis through linking its level of expression with the proliferative capacity of tumor cells. Chromogenic In Situ Hybridization Is a molecular procedure so as to join the colored signal discoverytechnique of immunohistochemistry with hybridization. CISH procedureworn to sense the attendance or lack of definitearea of DNA ,as perform in FISH technique . though, CISH is much more practical in diagnostic laboratories because it uses bright-field microscopes rather than the more expensive and complicated fluorescence microscopes used in FISH. CISH probes are connected with digoxigenin and can be recognized by bright-field microscope [8]. Aims of The Study recenthard work are focusing on detecting the genes and thoughtful the pathways concerned in disease succession, its forcefulperformance and treatment unwilling. PTEN is thought to be deleted in variety of tumors, particularly prostatic cancer, We hope in this study to clarify the genetic alteration of PTEN gene in patients with prostatic cancer in relation to Ki-67 which is a protein present in the nucleus and linked with ribosomal RNA combination, and the cell cycle progression (CCP) gain, to assess the proliferative capability of tumor cells.

Materials and methods

In this retrospective study, we used 50 paraffin embedded prostate cancersections from the records of branch of pathology in Al-Sader teaching hospital and the private laboratories with reference guide to thepatients files from the Middle Euphrates center for oncology. tissue samples were taken from patients went to physicians to be display a variety of prostate cancer symptoms such as frequent and urgenturination, difficulty in voiding and hematuria, and their prostate will be examined by one or more of these following procedures: digital rectal examination, PSA level assay, computed tomography, and MRI.We collect 50 sample for those with total prostatectomy and the trucut  biopsies that proved as prostate carcinoma, after we exclude  all the specimens that lacking the clinical date, full investigations, or those with a controversy about their diagnosis. All the clinical data were collected from patient file: age, ultrasonographic reports, preoperative serum PSA.

Sectioning of paraffin embedded blocks done by using the Leica rotary microtome in department of pathology/Al-Kufa Collage of Medicine, using extremely   fine steel blades, Paraffin sections are usually cut at a thickness 5µm ensuring that only a single layer of cells makes up the section. Sections are now “floated out” on the surface of warm water in a flotation bath to flatten them and then picked up onto microscope slides.
Staining the slides     
Before staining , the slides put in electric oven at 60°C to remove the paraffin from them, in about 30 minutes. The usual stain Hematoxylin and Eosin (H&E) is used to provide essential structural information about the specimens.After staining, the sections are covered with a glass coverslip.Interpretation of slides done by authors to grading them according to last updated Gleason score.
Detection (staining) system:DakoEnVision+ system-HRP(AEC) code K4004
Staining Procedure
relatePeroxidase building block,sufficientdiluted primary antibody or negative control reagent to coatblock, putadequate peroxidase connected Polymer, put adequate of the ready-to-use AEC+ substrate-chromogen, then put hematoxylin counterstain,then slides mounted and cover-slipped with an aqueous-based rising medium such as Glycerol Mounting Medium .
KI-67 Antibody Kit
Dilution: the dilution range of 1:100 when useful on paraffin sections. By take 20 minutes heating epitope recovery in Target Retrieval Solution, Low pH,and incubate at 20 min. with the primary antibody [9].
Evaluation of Staining Results
In evaluation of staining results for ki-67 expression we estimate the proportion of Ki-67-positive malignant  cells and divide the number by the total number of malignant cells within one HPF, and were categorised  into four degrees:grade 0 (< 1% of malignant cells),grade1 (1-10% of malignant cells)
grade 2 (11-30% of malignant cells),grade 3 (> 30% of malignant cells) [10]. For statistical analysis, the KI67 score categorized into dichotomous variable (?10%,>10%) as used byCuzick J et al in 2012 [13].
The Zytodot2C CISH Implantation Kit Protocol 
(ZytoDot 2C SPEC PTEN/CEN 10 Probe,code-3053)Molecular study of PTEN gene in which, Dual-color CISH was carried out on tissue sections, to map the PTEN gene on chromosome 10q23.3 region, the 5 µm tissue sections were de-paraffinized, proteolyses by pepsin solution, put in Pretreatment Solution EDTA , Heat in a covered staining jar standing in a boiling water bath to 37°C,50°C,then to at 95°C. Dehydration: in 70% , 90%, and 100% ethanol, each for 1 min.      
Air dry sections,denature the slides at 50°C for 5 min. then78-80°C for 5min., e.g. on a hot plate. transfer the slides to a humidity chamber and hybridize overnight at 37°C (e.g. in a hybridization oven).,remove the cover slips, immerse slides in 1x Wash Buffer TBS (prepared using WB5) and drain off or blot off the 1x Wash Buffer TBS. Apply Anti-DIG/DNP-Mix (AB14) dropwise (3-4 drops per slide) to the slides and incubate for 20 min. at 37°C in a humidity chamber.Then in the same manner apply HRP/AP-Polymer-Mix,AP-Red Solution, Apply HRP-Green Solution, counterstain and dehydrate the slides(modified from ZytoVision and ZytoDot of ZytoVision GmbH catalogue2015).
Then we counted chromogenic signals in 100 non-overlapping interphase nuclei for each sample, so PTEN gene deletion was defined in tumor nuclei that contain one or no 10q23.3 locus signal.               

Interpretation of CISH Results                                                               
The PTEN probe is labeled with digoxigenin (DIG), that results in permanent dark-green signals, the probe also labeled with dinitrophenyl (DNP) that results in permanent bright-red signals by using AP-Red solution.By this procedure we can detect 2 green and 2 red distinct dot –shaped signals with rounded edges in each nucleus in normal diploid cells, but in mitotic cells additional signals may be visible  (ZytoDot 2C CISH Implementation Kit catalogue2015).
Total lake of  probe spots (green spots) in ? 60% of malignant nuclei of the tissue specimens, considered as homozygous deletion of PTEN gene , with presence of  one or two green signals in the remaining nuclei, while absence of one probe signal ( green signal) in ? 60% of tumor nuclei of tissue spot, was defined as heterozygous deletion of PTEN gene. [10]


The mean age of patients participating in the current study was 68.18+8.72 years and their ages ranged from 48- 87 years. The division of patients according to 10 years intervals was outlined in table1. The mean of total prostatic specific antigen (PSA) serum level of the study population (preoperative measure) was 31.57+39.45 ng/ml and a median of 31.57 ng/ml. The range of PSA was (0.9 up to >100 ng/ml). The patients were classified into four groups according to the serum level of PSA as follows (Table-2).


The age distribution of our patients reflects the association of prostate cancer with old age patients as proved by Maria Svensson et al [14], who concluded that the tumor become more common with advancing age and had the average age of his patients 70 years. Were 40% of our patients are in 70-79 years intervals, and in seldom we find patient under 50 years (1 patient). In this study , there is high range of PSA level (0.9 - >100 ng/ml ) and there is high percentage of patients 40 %( 20/50) have PSA serum level > 20 ng/ml. this display the relative association between PSA level and prostate cancer, so the benefit of applying the screening program of measuring PSA serum level annually to every man aged more than 50 years is highly significant to be depended in our country as it was agreed by FDA in U.S. [14]. In immunohistochemical study of KI67 marker to all slides, we admix score 0+1 in one category (?10% of tumor cells), and admix score 2+3 in other category (> 10% of tumor cells), as it performed by Kazuhiro Tabata et al. [10] and Cuzick et al [13] to get more advantageous analysis.So the proliferative capacity of 29 cases (58%) is low compared to high proliferative capacity of 21 cases (42%), that’s reflects the relative high percent of production in prostate malignant cells, So the proliferative capacity of 29 cases (58%) is low compared to high proliferative capacity of 21 cases (42%), that’s reflects the relative high percent of proliferation in prostate cancer cells. In molecular study of PTEN gene status we used CISH technique as an alternative procedure to FISH, first because CISH is much more practical in diagnostic laboratories since it uses bright-field microscopes rather than the more expensive and complicated fluorescence microscopes used in FISH[13]. Second reason, is that we can get a permanent images to the slides ,permits to further evaluation of them by authors. Only a few studies have analyzed the frequency of PTEN deletion using FICH or CISH techniques , which are regarded as the gold standard for determination of gene copy numbers in tissue samples, or they used In the previous studies PTEN deletion were reported from 17%-68% [12], Maria Svensson et al in 2015(14), they identified PTEN gene deletion in 37.4% (68/182) 0f cases by CISH technique, heterozygous PTEN gene deletion was seen in 19.2% (35/182), and homozygous deletion was seen in 18.1% (33/182) of cases, these results in general be in agreement with our results. Association between PTEN gene status in CISH with KI67 The association between PTEN gene status examined by CISH technique with KI67 score performed byimmunohistochemical technique, is highly significant in statistical analysis (P= 0.003), in that we get 71.43% (25/35) of no deletion cases had KI67 score ?10% of cells, while in cases with PTEN gene deletion, we had 73.33% (11/15) of cases carry KI67 score >10% of cells. In addition we found that 100% of the homozygous PTEN gene deletion cases had KI67 score >10% of cells, while 63.63% of the heterozygous PTEN gene deletion cases had KI67 score >10% of cells. So the sensitivity of KI67 scoring test to detect PTEN gene status in prostate cancer is 73.33%, with 71.43 % specificity. But this test had 100% sensitivity to detect homozygous deletion of PTEN gene. The Odd Ratio is 6.8, 95% C.I = 1.76- 26.76, Z statistic= 2.78, significant level P= 0.0054. Krohnet al [12] found PTEN gene status and KI67 score data was significantly higher in PTEN deleted cases than in- undeleted cancers (P=0.03).


The KI67 score in IHC can detect in sensitive way the genomic state of PTEN gene, so we expect to have gene deletion in advanced KI67 score.


1.Meriç Tugba AKGUN, Nesrin TURACLAR and Hasibe Cingilli VURAL.A Study on PTEN Tumor Suppressor Gene Mutations in Turk Patients with prostate carcinoma.Int.J.Curr.Microbiol.App.2014;Sci 3(3): 791-803.
2.Gustafson S, Zbuk KM, Scacheri C, Eng C . Cowden syndrome. Semin Oncol.2007; 34:428–434.
3.Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgar ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV . Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet.1997; 15:356–362.
4.Lloyd KM II, Dennis M.Cowden s disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 58:136–142 gene, PTEN, in sporadic thyroid tumors. Cancer Res.1963; 57:4710–4713.
5.Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D . Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer.1998; 23:239–243.
6.Gerdes J, Schwab U, Lemke H, Stein H.(1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer.1983; 31:13-20
7.Bullwinkel J, Baron-Luhr B, Ludemann A, et al. Ki67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol.2006; 206:624-635.
8. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart M J, Isola J . "Chromogenic in situ hybridization: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples". The American Journal of Pathology.2000; 157 (5): 1467–72. doi:10.1016/S0002-9440(10)64785-2. PMC 1885742. PMID 11073807
9. Key G, Kubbutat MH, Gerdes J.Assessment of cell proliferation by means of an enzyme-linked immunosorbent assay based on the detection of the Ki-67 protein. J Immunol Methods.1994;177:113-117.
10.Kazuhiro Tabata,Tomonori Tanaka, Tomayoshi Hayashi, Takashi Hori, Sayuri Nunomura, SuguruYonezawaandJunya Fukuoka. Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered.BMC Clinical Pathology.2014;14:23
11.Konishi N, Nakamura M, Kishi M, Nishimine, M, Ishida E, Shimada k. Heterogeneous methylation and deletion patterns of the INK 4a/ARF locus within prostate carcinomas. Am J Pathol.2002; 160:1207-1410.1016/S002-9440(10)62547-62543.
12.Krohn A,Diedler T,Burkhardt L,Mayer PS,De Silva C,Meyer-Kornblum M,K?tschau D,Tennstedt P,Huang J,Gerh?user C,Mader M,Kurtz S,Sirma H,Saad F,Steuber T,Graefen M,Plass C,Sauter G,Simon R,Minner S and Schlomm T. Genomic deletion of PTEN is associated with tumor progression and early PAS recurrence in ERG fusion –positive and fusion –negative prostate cancer. Am J Pathol.2012;181(2):401-12
13.Cuzick J, Berney DM, Fisher G, Mesher D, Moller H, Reid JE, Perry M, Park J, Younus A, Gutin A. Foster CS, Scardino P, Lanchbury JS, Stone S on behalf of the Transatlantic Prostate Group . Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer.2012: 1095-1099.
14. Maria A Svensson, Roopika Menon, Jessica Carlsson, Wenzel Vogel, Ove Andrén, Michael Nowak and Sven Perner . Combination of Multiple Markers Predicts Prostate Cancer Outcome. J MolBiomark Diagn.2015;6:213.

The complete article is available as a PDF File that is freely accessible. The fully formatted HTML version can be viewed as HTML Page.

Medical Journal of Babylon

volume 13 : 3

Share |

Viewing Options

Download Abstract File
( 82 KB )

Related literature

Cited By
Google Blog Search
Other Articles by authors

Related articles/pages

On Google
On Google Scholar
On UOBabylon Rep

User Interaction

87  Users accessed this article in 1 year past
Last Access was at
24/06/2017 04:54:44